About Us
Home > About Us
Company Profile
Shijiazhuang Rainbowlabs Pharmaceutical Technology Co., Ltd. (referred to as " Rainbowlabs")was established in 2009 and specializes in Third-Party pharmaceutical testing services for the compliance testing of Drugs, Raw materials, APIs,Excipients and other pharmacopoeia grade materials. Rainbowlabs has established a quality management system in accordance with cGMP and ISO 17025 requirements, and has twice passed on-site audits by the U.S. FDA with0-483.
We’re proud to be the FDA and EU approved third-party laboratories, providing our top testing services to the multinational companies in the pharmaceutical world.

8000+
Number of Reports

40000+
Number of Projects

700+
Number of Method Validations

200+
Number of Clients
Development History
2009
Shijiazhuang Rainbowlabs Pharmaceutical Technology Co., Ltd. was founded.
2011
Obtained ISO9001 & UKAS international certifications.
2013
July: Passed the on-site audit by the U.S. FDA with "zero deficiencies".
2014
Obtained certification from Health Canada.
November: The laboratory passed the on-site review by the China National Accreditation Service for Conformity Assessment (CNAS).
November: The laboratory passed the on-site review by the China National Accreditation Service for Conformity Assessment (CNAS).
2016
June: The laboratory passed the on-site re-audit by the U.S. FDA with "zero deficiencies" again.
2017
November: The laboratory passed the re-accreditation review by CNAS.
2024
May: The laboratory passed the CNAS scope expansion of competence and re-accreditation review.
Corporate Culture

Vision
Bridge for domestic pharmaceutical enterprises to enter high-end European & American markets

Mission
International Cooperation Partner, Assistant for European & American Markets, Supply Chain Escort

Behaviors
Impartiality, Scientific Methods, Accuracy & Timeliness, Continuous Improvement

Ideals
Integrity, pragmatism, cooperation, win-win
Qualifications and Honors
- Corporate Honors
- Company Qualifications
Online Message













